The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity.
about
Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgeryPopulation pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureusPopulation pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
P2860
The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@ast
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@en
type
label
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@ast
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@en
prefLabel
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@ast
The use of a change in gentami ...... amicin-induced nephrotoxicity.
@en
P1476
The use of a change in gentami ...... tamicin-induced nephrotoxicity
@en
P2093
Chris Frampton
Evan J Begg
P304
P356
10.1097/00007691-200310000-00012
P577
2003-10-01T00:00:00Z